Availability of genome-matched therapy based on clinical practice Naomi HayashiSeiichi MoriShunji Takahashi Original Article Open access 26 April 2024
Significance of radiation therapy in the myxoid round-cell liposarcoma treatment regimen Akiyoshi ShimataniHirohisa KatagiriTsuyoshi Onoe Original Article 24 April 2024
SlicerPIT: software development and implementation for planning and image-guided therapy in photoimmunotherapy Takayoshi SuzukiSatoshi KanoAkihiro Homma Original Article 23 April 2024
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022 Tetsuhiro YoshinamiKazuki NozawaToshimi Takano Special Article 23 April 2024
Short- and long-term post-nephrectomy outcomes for retroperitoneal liposarcoma from a high-volume sarcoma center: a propensity score matching analysis Guoqiang XueZhen WangChunyi Hao Original Article 23 April 2024
Biomarker-oriented chemo-immunotherapy for advanced gastric cancer Koji KonoShotaro NakajimaKosaku Mimura JSCO Board of Directors Series 22 April 2024
Clinicopathological characteristics of Lynch-like syndrome Sakiko NakamoriMisato TakaoTatsuro Yamaguchi Original Article 20 April 2024
A Japanese multi-institutional phase II study of moderate hypofractionated intensity-modulated radiotherapy with image-guided technique for prostate cancer Katsumasa NakamuraKeiji NiheiYoshikazu Kagami Original Article 17 April 2024
New therapeutic target molecules for gastric and gastroesophageal junction cancer Hisato Kawakami Invited Review Article 17 April 2024
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs: approval of nivolumab for unresectable advanced or recurrent epithelial skin malignancies in Japan Noriomi MatsumuraMasaki Mandai PMDA Regulatory Update 16 April 2024
Early experience and future prospects regarding use of newly developed surgical robot system, hinotori, in the field of urologic cancer surgery Hideaki MiyakeMasato Fujisawa JSCO Board of Directors Series Open access 16 April 2024
Current status and prospects of artificial intelligence in breast cancer pathology: convolutional neural networks to prospective Vision Transformers Ayaka KatayamaYuki AokiTetsunari Oyama Invited Review Article 15 April 2024
Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome Tetsuya ItoTatsuro YamaguchiHideyuki Ishida Original Article Open access 14 April 2024
English version of Japanese Clinical Practice Guidelines 2022 for gastrointestinal stromal tumor (GIST) issued by the Japan Society of Clinical Oncology Seiichi HirotaUkihide TateishiMembers of the Systematic Review Team of the Present Guidelines Special Article Open access 13 April 2024
Progressive changes in the protein expression profile of alveolar septa in early-stage lung adenocarcinoma Toru KimuraTakashi AkazawaJiro Okami Original Article 11 April 2024
Preoperative predictive factors for positive peritoneal cytology results in patients with pancreatic ductal adenocarcinomas: a retrospective study Gaku ShimaneYutaka NakanoYuko Kitagawa Original Article 10 April 2024
Modified neoadjuvant rectal score as a novel prognostic model for rectal cancer patients who underwent chemoradiotherapy Kazushige KawaiKosuke OzakiSoichiro Ishihara Original Article 09 April 2024
Psoas mass index at the level of the third lumbar vertebra on computed tomography is a prognostic predictor for metastatic castration-sensitive prostate cancer Shunsuke OwaTakeshi SasakiTakahiro Inoue Original Article 08 April 2024
Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab Takeru WakatsukiNaoki IshizukaDaisuke Takahari Original Article Open access 08 April 2024
Development and validation of a nomogram to predict overall survival in patients with redefined anaplastic thyroid carcinoma based on the SEER database Chuyue ZhangBin LiYan Yang Original Article Open access 07 April 2024
MMP1, IL-1β, sTNFR-1, and IL-6 are prognostic factors for patients with unresectable or metastatic renal cell carcinoma treated with immune checkpoint inhibitors Hirotaka NagasakaTakeshi KishidaTetsuro Sasada Original Article Open access 06 April 2024
Impact of disease volume on survival efficacy of triplet therapy for metastatic hormone-sensitive prostate cancer: a systematic review, meta-analysis, and network meta-analysis Akihiro MatsukawaPawel RajwaTakafumi Yanagisawa Review Article Open access 06 April 2024
Effectiveness of G-CSF in chemotherapy for digestive system tumors: a systematic review of the Clinical Practice Guidelines for the Use of G-CSF 2022 delineated by the Japan Society of Clinical Oncology Mamoru ItoYuta OkumuraKenji Tsuchihashi Special Article 05 April 2024
Magnesium supplementation therapy to prevent cisplatin-induced acute nephrotoxicity in pediatric cancer: a randomized phase-2 trial Motohiro MatsuiAtsushi MakimotoYuki Yuza Original Article 02 April 2024 Pages: 629 - 637
Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy Taha Koray SahinYakup OzbayOmer Dizdar Original Article 02 April 2024
Lymphatic drainage patterns of malignant skin tumors in the head and neck region: a single-center retrospective study Takuya NishioTaku MaedaToshihiko Hayashi Original Article 30 March 2024 Pages: 582 - 591
Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma Sho IwakiShigenori KadowakiNobuhiro Hanai Original Article 30 March 2024
Bridging horizons beyond CIRCULATE-Japan: a new paradigm in molecular residual disease detection via whole genome sequencing-based circulating tumor DNA assay Tadayoshi HashimotoYoshiaki NakamuraTakayuki Yoshino JSCO Board of Directors Series Open access 29 March 2024 Pages: 495 - 511
PMDA regulatory update on approval of new drugs and revisions of precautions; approval of talazoparib tosilate for prostate and breast cancer, and luspatercept for myelodysplastic syndrome in Japan Noriomi MatsumuraMasaki Mandai PMDA Regulatory Update 29 March 2024 Pages: 493 - 494
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of G-CSF 2022 Shoji KimuraKeisuke ShigetaYuji Miura Special Article 28 March 2024 Pages: 559 - 563
MRI-based volumetric tumor parameters before and during chemoradiation predict tumor recurrence and patient survival in locally advanced cervical cancer: a subgroup analysis of a phase II prospective trial Han Byul KangSung Hwan KimJong Hoon Lee Original Article 26 March 2024 Pages: 620 - 628
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022 Yukinori OzakiTakamichi YokoeToshimi Takano Special Article 25 March 2024 Pages: 551 - 558
PD-L1 expression and microsatellite instability (MSI) in cancer of unknown primary site João Neif Antonio JuniorDaniel D.’Almeida PretoFlavio Mavignier Cárcano Original Article Open access 25 March 2024
Favorable clinical efficacy of cytotoxic chemotherapy in patients with progressive desmoid tumors: a retrospective real-world study Chung Ryul OhHyehyun JeongJin-Hee Ahn Original Article 25 March 2024
Local excision versus radical surgery for anal squamous cell carcinoma: a multicenter study in Japan Shin MuraiHiroaki NozawaSoichiro Ishihara Original Article Open access 25 March 2024
A real-world study of treatment sequences and second-line clinical outcomes in patients with HER2-positive metastatic breast cancer in US community practice Della VargheseGiovanna I. CruzHenry G. Kaplan Original Article Open access 25 March 2024
Sarcopenia is associated with leukopenia in urothelial carcinoma patients who receive tislelizumab combined with gemcitabine and cisplatin therapy Zhimin GaoYubin PangHailong Li Original Article Open access 22 March 2024 Pages: 592 - 601
Effectiveness and safety of primary prophylaxis of granulocyte colony-stimulating factor during dose-dense chemotherapy for urothelial cancer: Clinical Practice Guidelines for the Use of G-CSF 2022 Keita UchinoShingo TamuraYuji Miura Special Article 22 March 2024 Pages: 545 - 550
Macroscopic type is implicated in the prognostic impact of initial chemotherapy on peritoneal lavage cytology-positive gastric cancer with no other noncurative factors Yosuke KanoHiroshi IchikawaToshifumi Wakai Original Article 21 March 2024
Effectiveness and safety of primary prophylaxis with G-CSF after induction therapy for acute myeloid leukemia: a systematic review and meta-analysis of the clinical practice guidelines for the use of G-CSF 2022 from the Japan society of clinical oncology Tomoya MaedaYuho NajimaShingo Yano Special Article Open access 18 March 2024 Pages: 535 - 544
Clinical practice guidelines for molecular tumor marker, 2nd edition review part 2 Yoshinori KikuchiHideaki ShimadaHiroyuki Takahashi Special Article 17 March 2024 Pages: 512 - 534
Salivary gland-type cancers: cross-organ demographics of a rare cancer Aika TanzawaKengo SaitoYuichi Takiguchi Original Article Open access 16 March 2024
An approach for improvement of the accuracy of cancer gene panel testing Kiyomi ImotoHiroyuki YamamotoYu Sunakawa Original Article 12 March 2024 Pages: 571 - 581
Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab Masaki HashimotoWataru FukuokayaTakahiro Kimura Original Article 02 March 2024 Pages: 612 - 619
Association of D-dimer level with thrombotic events, bleeding, and mortality in Japanese patients with solid tumors: a Cancer-VTE Registry subanalysis Mashio NakamuraMasato SakonMasataka Ikeda Original Article Open access 02 March 2024 Pages: 407 - 416
Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study Rikiya TaokaMasaki KamadaMikio Sugimoto Original Article 28 February 2024 Pages: 602 - 611
Current status of head and neck sarcomas in Japan in 2016–2019: an analysis using the national cancer registry Ryoko RikitakeYu MizushimaAkira Kawai Cancer Statistics Open access 27 February 2024 Pages: 564 - 570
Plasma THBS1 as a predictive biomarker for poor prognosis and brain metastasis in patients with HER2-enriched breast cancer Yang LiJun QinXing Sun Original Article 27 February 2024 Pages: 427 - 441
Financial toxicity and patient experience associated with financial burden of molecular-targeted and immune therapies for cancer: an observational study under public health insurance Sena YamamotoChiharu KondohHarue Arao Original Article Open access 24 February 2024 Pages: 417 - 426
Abnormal activation of RFC3, A YAP1/TEAD downstream target, promotes gastric cancer progression Zijun GuoLin Guo Original Article 21 February 2024 Pages: 442 - 455
